NCT00601172 2018-01-17A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.GlaxoSmithKlinePhase 3 Completed710 enrolled 29 charts
NCT00431236 2017-08-22A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic ChemotherapyGlaxoSmithKlinePhase 3 Completed810 enrolled
NCT00891761 2015-04-17A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic ChemotherapyGlaxoSmithKlinePhase 3 Withdrawn